World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

PureHealth Research Utilizes Bioavailable Cranberry and Astragalus in Premium Natural Supplements for Kidney Health

Cision PR Newswire by Cision PR Newswire
June 13, 2026
in Press Releases - Lifestyle
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

MANASSAS, Va., June 13, 2026 /PRNewswire/ — PureHealth Research today addressed the growing demand for proactive kidney wellness with its collection of science-backed renal health formulas. The products draw on carefully selected ingredients – including Turmeric, Magnesium, and Probiotics – to support healthy kidney function, fluid balance and the body’s natural filtration processes.

 

PureHealth Research (PRNewsfoto/PureHealth Research LLC)

 

Supporting the Body’s Natural Filtration System

The kidneys are the body’s primary filtration system, working continuously to remove cellular waste, maintain fluid balance, regulate electrolyte levels, and support overall wellness. Over time, aging, everyday lifestyle habits, and environmental stressors could place added demands on normal kidney function.

To support optimal renal wellness, PureHealth Research formulates its premium natural supplements for kidney health with carefully selected nutrients and botanical compounds – including Turmeric (Curcumin), Magnesium and Probiotics – that work together to promote healthy renal function, antioxidant support and hydration balance.

Key Benefits

  • Healthy Filtration Support: Utilizes targeted nutrients and botanical compounds to support the kidneys’ natural ability to filter cellular waste and maintain healthy function.
  • Fluid & Electrolyte Balance: Delivers ingredients such as Magnesium to help support healthy hydration and electrolyte regulation throughout the body.
  • Antioxidant Protection: Features Curcumin from Turmeric to help support the body’s natural defenses against oxidative stress and promote renal tissue wellness.

The science behind this targeted nutritional approach to kidney wellness and healthy aging continues to grow. To see how the right nutrients could support the body’s natural filtration processes and fluid balance, explore PureHealth Research’s natural supplements for kidney health.

About PureHealth Research

PureHealth Research is dedicated to advancing proactive health through science-backed nutrition. Each formula is approved by credentialed medical experts and tested by independent third-party laboratories for purity, potency, and heavy metals, then manufactured in US-based, cGMP-certified facilities using natural, non-GMO ingredients that are dairy-free, soy-free, and gluten-free.

Logo: https://mma.prnewswire.com/media/2902972/PureHealth_Research_Logo.jpg

PureHealth Research LLC
support@purehealthresearch.com
+1 (888) 558-9836 (Toll-Free, US)
+1 (863) 301-4007 (International)
10199 Dean Drive, Manassas, VA 20110, USA

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/purehealth-research-utilizes-bioavailable-cranberry-and-astragalus-in-premium-natural-supplements-for-kidney-health-302792585.html

SOURCE PureHealth Research LLC

Cision PR Newswire

Cision PR Newswire

Related Posts

Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

June 13, 2026

Verra Mobility Corporation (VRRM) Securities Fraud Class Action Lawsuit Filed; August 4, 2026, Lead Plaintiff Deadline

June 13, 2026

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

June 13, 2026

TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

June 13, 2026

Growing Consumer Interest in Natural Supplements for Thyroid Health Leads PureHealth Research to Highlight Iodine, Selenium, and Ashwagandha

June 13, 2026

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

June 13, 2026

Popular News

  • Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

    0 shares
    Share 0 Tweet 0
  • Verra Mobility Corporation (VRRM) Securities Fraud Class Action Lawsuit Filed; August 4, 2026, Lead Plaintiff Deadline

    0 shares
    Share 0 Tweet 0
  • Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

    0 shares
    Share 0 Tweet 0
  • TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

    0 shares
    Share 0 Tweet 0
  • Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler